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basal ganglia1. It is characterized by the typical 
history of a progressive neurological disorder, with 
resting tremor, muscle stiffness and hypokinesia2.
In a study of the literature3 reported that neuro-
degeneration in patients with PD may result from an 
alteration in the riboflavin concentration (vitamin B2). 
The authors document a progressive and noticeable 
improvement of the motor capacity in 19 patients 
with PD, who started receiving riboflavin orally and 
had red meat and poultry removed from their diet for 
a period of six months. Biochemical data obtained 
from patients with sporadic PD indicate vitamin B2 
deficiency in such patients4. Even though they kept a 
diet that includes riboflavin intake, 10-15% of London 
and Florence inhabitants presented low activity of 
two riboflavin-dependent enzymes. This figure might 
reflect the percentage of the world population with 
regards to the alteration in riboflavin absorption, and 
  INTRODUCTION
Parkinson’s Disease (PD) is the most common 
disorder of the extrapyramidal system, and it is 
a neurodegenerative disease resulting from a 
decrease in the dopaminergic transmission in the 
ABSTRACT
Purpose: to verify the quantitative changes in the swallowing dynamics in patients with Parkinson´s 
disease submitted to treatment with riboflavin, red meat and poultry removed during one year period. 
Methods: sixteen patients with Parkinson´s disease participated in the study; the mean age was 67.25 
years, the mean degree of disease severity was II to III, and the mean time since the diagnosis of 
the disease was 3.5 years. Videofluoroscopic evaluations were performed before and one year after 
treatment with riboflavin and diet with restriction of read meat and poultry. Analyzed were: presence 
of complaints related to swallowing and quantitative analyses of swallowing includind computerized 
measurements of hyoid bone and cricoid cartilage displacement, opening of the superior esophageal 
sphincter and pharyngeal constriction. Results: decrease of complaints was observed after 
administration of riboflavin. About the quantitative measures after riboflavin, there were a increase 
in the opening of the superior esophageal sphincter for all consistencies offered, an increase in the 
pharyngeal constriction for the thickened liquid, a reduction in the hyoide bone displacement, and 
an increase or a reduction in the cricoid cartilage displacement for each consistency, with significant 
reduction for the liquid. Conclusion: quantitative measurements made in the movement of organs 
associated with swallowing showed no significant differences between pre-and post-riboflavin, and 
red meat and poultry removed.
KEYWORDS: Deglutition; Deglutition Disorders; Parkinson Disease; Riboflavin; Fluoroscopy
1126 Silvério CC, Coimbra CG, Chiari BM, Lederman HM, Gonçalves MIR
Rev. CEFAC. 2014 Jul-Ago; 16(4):1125-1132
submitted to riboflavin intake and restriction of red 
meat and poultry for one year.
  METHODS
This research was approved by the Federal 
University of São Paulo State/São Paulo Hospital 
Comitê de Ética em Pesquisa (Research Ethics 
Committee), Protocol 0360/06.
Sixteen PD patients participated in this study 
(8 men and 8 women), at an average age of 67.25 
years, an average severity level of the disease from 
II to III according to the Adapted Hoehn & Yahr 
Scale11 and the average PD diagnosis time of 3.5 
years. At the beginning of the study, 14 patients had 
already been taking PD medication, and this was 
not interrupted for the study. No patient underwent 
speech therapy during the study period. After video-
deglutogram were performed orientations when 
necessary, regarding food consistency and forms of 
offer.
not only represents a specific alteration of a certain 
ethnic group5. 
Swallowing disorders in Parkinsonism may be 
present at different levels, affecting oral, pharyngeal 
and esophageal phases6. Studies7,8 report that 
patients with PD often develop dysphagia in the 
course of their disease, having difficulties to start 
swallowing and occasionally pulmonary aspiration 
of liquids, what impairs the individuals’ clinical, nutri-
tional and hydration state and leads to complications 
such as malnutrition and aspiration pneumonia. 
Studies in the Parkinson’s literature report that 
pneumonia is the most common cause of deaths 
among patients with PD9,10.  
About the motor gain presented by patients with 
PD submitted to the administration of riboflavin 
and restriction of red meat and poultry3, began this 
research to determine whether these gains could 
also be applied to swallowing, as there are changes 
in the dynamics of swallowing in PD
The purpose of this study was to analyze 
quantitative changes in the swallowing dynamics 
in patients with Parkinson’s disease, who were 
Table 1 – Data relating to age, sex, disease duration and disease stage according to the modified 
scale of functionality Hoehn & Yahr11
Patient Sex Age (years)
Disease duration 
(years) Disease stage
1 F 75 4 IV
2 M 50 1 II
3 M 64 2 II
4 M 76 5 II to III
5 M 55 5 IV
6 F 67 9 II
7 M 55 4 II to III
8 F 74 8 V
9 F 67 1 II to III
10 F 64 5 II to III
11 M 66 4 II to III
12 F 72 1 II
13 F 76 1 II to III
14 F 79 2 II to III
15 M 65 1 II to III
16 M 71 4 II to III
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the resting-state image was overlapped with the 
maximum excursion image and a right line was 
then traced, thus joining both intersections of 
both situations; 
•	 maximum displacement of the cricoid cartilage: 
tracing of resting-state images, as well as the 
moment of higher elevation of the hyoid/laryngeal 
complex, were made. Initially, two tangent lines 
were traced, one to the free border level of the 
vocal folds, and the other to the anterior wall of 
the trachea, a little below the larynx. The crossing 
of these two tangent lines with two other fixed 
lines was selected, thus comprising a 90° right 
angle in one of the cervical vertebrae, copying 
this selected image. Thereupon, the same 
procedure of tangent lines was carried out on 
the free border of the vocal folds and the trachea 
of the 90° angle, on the same vertebra used on 
the resting state, on the image of higher larynx 
elevation. At that moment, the selected resting-
-state image was overlapped, thus allowing the 
cricoid cartilage displacement to be measured; 
•	 maximum pharyngeal constriction: measurement 
made between the difference of both pharynx in 
resting state and its area occupied either by air 
or food residues at the moment of pharynx higher 
constriction during swallowing. The tracing of 
the resting-state image started in the anterior 
tubercle of the atlas vertebra, following inferiorly 
towards the arytenoid cartilage and the upper part 
of the vocal folds. It followed superiorly, outlining 
the epiglottis, the base of tongue and the velum 
until it reached the posterior nasal spine of the 
horizontal plate of the palatine bone. As for the 
image for higher pharyngeal constriction, either 
the food residue area or the remaining air space 
was outlined;   
•	 maximum pharyngoesophageal transition (PET): 
maximum opening for food passage during 
swallowing. For this measurement to be made, 
we chose the moment of higher opening of 
sphincter, in a 1-cm region below the level of the 
vocal folds, thus taking opening measurement 
by tracing a horizontal line in the extension of the 
entire food bolus column. Measurement of the 
upper esophageal sphincter was considered null 
in the resting state.  
The authors understand by the terminology of 
functionality in the swallow, the occurrence of this 
function safely and effectively, without risking the 
protection of the lower airways, and at a time able to 
keep the nutritional aspects appropriately.
In order to analyze the results, significance (p) 
level of 5% (0,05) was adopted. Statistical signifi-
cances is marked with an asterisk (*).  
The patients were referred to the doctor in charge 
of riboflavin administration before the beginning of 
this treatment. According to the doctor, each patient 
received 30 mg every eight hours, totaling 90 mg of 
riboflavin daily. Red meat and poultry restriction was 
mandatory during the study, and the patient was 
advised by the medical team to replace that diet with 
other protein sources. It is worth mentioning that, 
every three months, each patient’s serum ferritin 
was analyzed by the medical team, so that it was 
possible to confirm that their iron reserves were 
within normal limits.
The patient was initially asked whether they had 
any swallowing-related complaints. Later on, the 
target swallowing study was conducted by means 
of the videofluoroscopic swallowing study (VFSS), 
following the Federal University of São Paulo State 
– Medicine School of São Paulo protocol12. During 
the study, the patient was kept in a osthostatic, 
lateral and front positions. The test was carried out 
with the EDR-750B X-ray device, and the videos 
were recorded with an X690 Semp camcorder. In 
the analysis of this study, the following offers were 
considered: 5 ml of a thin liquid (water + barium) 
offered in a syringe; 5 ml of a thick liquid (pure 
barium) offered in a syringe; 5 ml of a semi-solid 
mixture (yogurt-like sweet fromage frais + barium) 
offered with a spoon; and a solid mixture (a small 
piece of cheese bread + barium).      
A year after riboflavin intake, the patients were 
recalled and again submitted to the whole procedure 
above described, so that it was possible to analyze 
the development of the swallowing dynamics 
process. 
In the analysis of the VFSS, swallowing-related 
structures were measured by means of an image 
processing program, the ImageJ13, developed 
by the National Institute of Health. For such 
analysis, appropriate lateral view images for each 
measurement were selected and digitalized. For 
program calibration, in order to get information 
on the distance or area selected in centimeters in 
each image, a metal marker was used – placed in 
the mastoid region –, thus allowing to provide the 
program with its diameter value. The measurements 
taken were:
•	 maximum displacement of the hyoid bone 
– image tracings were made on the resting-
-state images and at the moment of maximum 
excursion of the hyoid/laryngeal complex during 
swallowing. Initially, the intersection between a 
tangent line to the anterior portion of the hyoid 
bone and another tangent line to the inferior 
margin was considered. Next, a right angle 
was traced – always considering the same 
individual’s cervical vertebrae. At a later time, 
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swallowing, since he PET opening is strictly related 
to the hyo-laryngeal complex raise, such as a lever 
system, and to the food bolus volume and consis-
tency as well.
Variations in the maximum pharyngeal 
constriction percentage (Table 3) did not obtain 
statistical significance, and showed both values 
lower than or greater constriction, depend of the 
food consistency analyzed, when comparing the 
two moments.  
The maximum displacement of the hyoid bone 
(Table 3) were difficult to read, due to the variety 
of its movement standards. A slight reduction in its 
displacement values was observed, with no inter-
ference in swallowing functional aspects. 
  RESULTS
Sixteen patients participated in this study. 
However, due to the image quality of the VFSS 
which, at times, did not allow for reliable assessment 
of the results, a lower N occurs in some tables.
It is possible to observe in Table 2 the percentage 
of complaints in PD patients in the pre and post 
riboflavin moments. The analysis of the complaint 
was made by its presence or absence. The authors 
did not relate the specificity of complaints. 
The maximum PET opening showed variations 
in comparing the two moments, with no statistical 
significance, with a slight increase at the post taking 
moment (Table 3) for all the consistencies analyzed. 
This comparison might suggest a more efficient 
Table 2 – Numerical and percentage distribution of patients according to the presence or absence of 
complaints related to swallowing, in the pre-and post-riboflavin (p=0,257).
Moment Complaint TotalAbsense Presence
N (%) N (%) N (%)
Pre  6 (37,5) 10 (62,5) 16 (100)
Post 9 (56,25) 7 (43,75) 16 (100)
Legend: N= number of patients; %= percentage.
Table 3 – Numerical distribution, mean and standard deviation of the variable maximum PET, maximum 
pharyngeal constriction, maximum displacement of the hyoid bone and maximum displacement of 
the cricoid cartilage, in centimeters, for consistencies thin liquid, thick liquid, pasty and solid in pre 
and post-administration of riboflavin.
Consistency
Maximum PET Pharyngeal constriction Hyoid bone displacement Cricoid cartilage displacement
N SD p N SD p N SD p N SD p
L
pre 16 0,84 0,29
0,170
15 93,48 3,98
0,910
16 2,70 0,85
0,266
16 2,22 0,62
0,030*
post 16 0,94 0,27 16 93,15 4,57 16 2,38 0,73 16 1,86 0,50
TL
pre 15 0,89 0,18
0,394
13 87,41 10,92
0,311
15 2,71 0,65
0,932
15 2,12 0,68
0,691
post 16 0,97 0,26 16 88,79 7,72 16 2,59 0,91 16 2,16 0,59
P
pre 16 0,97 0,25
0,346
15 91,83 5,91
0,733
16 2,48 0,56
0,737
16 2,07 0,69
0,897
post 16 1,03 0,31 15 91,66 5,82 16 2,44 0,64 16 2,13 0,65
S
pre 16 1,20 0,39
0,660
15 91,12 5,14
0,363
16 2,83 0,79
0,979
16 2,25 0,56
0,623
post 16 1,21 0,31 16 90,77 9,23 16 2,77 0,81 16 2,21 0,55
Legend: = mean; N= number of patients; SD= standard deviation; p= significance; PET= pharyngoesophageal transition; L= thin 
liquid; TL= thick liquid; P= pasty; S= solid.
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range, but this comparison may be questioned by 
the difference in the volume offered.
Data found were similar for all the study 
patients, even those that did not engage in using 
the medication for PD. Analyzing the tests in a 
qualitative way, according to the clinical practice of 
the authors, the swallowing of the patients in study 
were classified as normal both times. This finding 
suggests that the patients in this study did not show 
changes that could compromise the safety and 
efficacy of swallowing.
The cricoid cartilage displacement (Table 
3) shows sometimes a slight increase of the 
displacement index, sometimes slight reduction. To 
the thin liquid consistency, a significant reduction in 
this displacement was found, although interference 
in swallowing functional aspects was not observed.
Table 4 shows the comparison of the data found 
in maximum opening of PET and displacement of 
the hyoid bone in this study, with data of normal liter-
ature14. Can be verify that the data of the patients 
in this study are higher compared with the normal 
Table 4 – Comparison of the numerical distribution, mean and standard deviation of the variable 
maximum PET and maximum displacement of the hyoid bone in centimeters for thin liquid consistency, 
in the pre-and post-administration of riboflavin, with data from the literature14
Consistencies Volume(milliliters)
PET Hyoid bone displacement
N SD N SD
L pre 5 16 0,84 0,29 16 2,70 0,85
L post 5 16 0,94 0,27 16 2,38 0,73
L literature 3 60 0,51 0,15 60 1,86 0,60
Legend: = mean; N= number of patients; SD= standard deviation; p= significance; PET= pharyngoesophageal transition; L= thin 
liquid. 
  DISCUSSION
Prevalence of dysphagia in PD demonstrates 
the need for speech therapy activity in these 
patients, and the understanding by this profes-
sional regarding the pharmacological interference 
in the pathophysiology of swallowing. According to 
the literature7,8, the presence of dysphagia in PD is 
common, especially with the progression of disease, 
leading to clinical disorders, including the occur-
rence of malnutrition, dehydration and aspiration 
pneumonia, due to changes in swallowing function 
. According pesquisa15 performed, the average 
lifespan of PD patients after the onset of symptoms 
of dysphagia shall be 24 months. 
As some studies report in the literature16,17 the 
swallowing-related complaints in patients with PD 
may not frequently be correlated with the process 
itself. The decrease of the complaints in this study 
in the post-riboflavin may suggest optimizing in the 
patients perceptions of symptoms presented, which 
does not indicate an improvement in the function 
itself.
Authors18 observed higher UES opening when 
more dense pure barium was swallowed than when 
less dense pure barium was swallowed. In another 
study19 the authors suggest to use thickened liquid 
in order to reduce tracheal aspiration of thin liquid. 
In a research20 the authors conclude that swallowing 
thickened liquid is safer than swallowing thin liquid 
for patients with PD. It was observed at VFSS of 
patients who participated in this study that this 
consistency presented more representative food 
stasis than the others, which might explain the 
fact that pharyngeal constriction occurs at a higher 
proportion in this consistency, aiming at inducing 
higher pressure for food bolus to go down. 
In the literature, the analysis of the hyoid bone 
displacement is divided into anterior displacement 
and vertical displacement. Therefore, it makes 
comparison of data in this study difficult. In the 
studies, some authors21 state that the anterior 
displacement of the hyoid bone is more variable, 
whereas another authors22 report that the anterior 
displacement of the hyoid bone is less variable, 
as well as larger when compared with its vertical 
displacement. They also state that the amplitude of 
the vertical displacement of the hyoid bone varies 
according to food consistency.  
Quando comparados com dados da liter-
atura14,23-29 os valores das medidas de máximo 
deslocamento do osso hióide, máxima constrição 
da faringe, e máxima abertura da TFE encon-
traram-se maiores, mesmo na comparação com 
indivíduos não disfágicos. Tal fato pode ser decor-
rente de metodologias diferentes na realização das 
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promoting lower strength, and consequent less 
displacement, by the individual.
The differences found before and after taking 
riboflavin, even though some differences had statis-
tical significance, did not influence those patients’ 
swallowing functional aspects, given that, a year after 
the study was conducted, those patients’ swallowing 
was safe and efficient. In the study group, there was 
no influence on swallowing pattern displayed by 
patients with the use of riboflavin and restriction of 
red meat and poultry. It is believed that if the analysis 
performed in this study occurred in patients with PD 
who presented swallowing disorders more apparent, 
the results could be different. Thus, it is suggested 
to continuing studies of quantitative measurement in 
PD patients subjected to this intervention.
  CONCLUSION
In conclusion, quantitative measurements 
made in the movement of organs associated with 
swallowing showed no significant differences 
between pre-and post-riboflavin, and red meat and 
poultry removed.
medidas, impedindo uma comparação entre esses 
dados. A Tabela 4 demonstra a comparação de 
duas variáveis do estudo (abertura da TFE e deslo-
camento do osso hioide) com dado de literatura14.
Compared to the data in the literature14,23-29 the 
measurement values of the hyoid bone displacement, 
maximum pharyngeal constriction and maximum 
UES opening were found to be higher, even when 
compared to nondysphagic individuals. Such a fact 
may result from different methods to take measure-
ments, thus preventing a comparison of these data. 
Table 4 shows the comparison of two variables in 
the study (PET opening and displacement of the 
hyoid bone) with data of literature14.
From a study in which higher hyoid bone 
displacement values for nondysphagic elderly 
people in comparison to young people were found, 
the authors30 conclude that this deviation may be 
a result from a lower position of the larynx in elder 
people’s necks.
The data of the significant reduction in the 
cricoid cartilage rise tor the thin liquid consistency 
does not influence the functionality and efficiency 
of swallowing. It occurred possibly because of this 
consistency requires less pressure to swallow, 
RESUMO
Objetivo: verificar as mudanças quantitativas na dinâmica da deglutição em pacientes portadores 
da doença de Parkinson, submetidos à administração de riboflavina e restrição de carnes vermelhas 
e de aves, no período de um ano. Métodos: participaram do estudo 16 pacientes com doença de 
Parkinson, com media de idade de 67,25 anos, media do nível de severidade da doença de II para III 
e com media de 3,5 anos de tempo de diagnóstico da doença. As avaliações videofluoroscópicas da 
deglutição foram realizadas antes e após um ano de administração de riboflavina e restrição de carne 
vermelha e de aves. Foram analisadas: presença de queixas relacionadas à deglutição e análise 
quantitativa por meio de medidas computadorizadas do deslocamento do osso hióide e da cartila-
gem cricóidea, abertura da transição faringoesofágica (TFE) e da constrição da faringe. Resultados: 
verificou-se redução no percentual de queixas relacionadas à deglutição no momento pós-adminis-
tração de riboflavina. Com relação às medidas quantitativas, observou-se no momento pós um dis-
creto aumento na abertura da TFE para todas as consistências oferecidas, aumento da constrição 
da faringe para a consistência líquido engrossado, discreta redução dos valores de deslocamento do 
osso hióide, e tanto discreta redução como discreto aumento dos valores de deslocamento da car-
tilagem cricóidea dependendo da consistência alimentar, sendo redução significante para o líquido. 
Conclusões: as medidas quantitativas realizadas na movimentação dos órgãos relacionados à 
deglutição não demonstraram diferenças significantes entre os momentos pré e pós-riboflavina e a 
restrição de carne vermelha e de aves. 
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